Ekso Bionics Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Note 7 - Accrued Liabilities

Note 7 - Accrued Liabilities

3 Months Ended

Mar. 31, 2024

Notes to Financial Statements

Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]

7. Accrued Liabilities

Accrued liabilities consisted of the following:

	*March 31, 2024*		*December 31, 2023*
Salaries, benefits and related expenses	$	1,275	$	2,058
Device warranty		404		461
Other		107		145
Total	$	1,786	$	2,664

Warranty

The current portion of the device warranty liability is classified as a component of Accrued liabilities, while the long-term portion of the device warranty liability is classified as a component of Other non-current liabilities in the condensed consolidated balance sheets. A reconciliation of the changes in the device warranty liability for the three months ended March 31, 2024 is as follows:

	*Three Months Ended*
	*March 31, 2024*
Balance at beginning of the period	$	566
Additions for estimated future expense		121
Incurred costs		(161	)
Balance at end of the period	$	526

	*Balance as of March 31, 2024*
Current portion	$	404
Long-term portion		122
Total	$	526